Company News 30 Apr 2024 Remplirâ„¢ nerve repair study published in peer-reviewed clinical journal Orthocell has announced that results from the Remplirâ„¢ nerve regeneration clinical trial have been published in a high profile clinical… Orthocell
Company News 15 Apr 2024 Orthocell receives $3.05m R&D tax incentive refund Orthocell has announced that it has received a Research and Development (R&D) Tax Incentive refund of A$3,051,483 for the financial… Orthocell
Video 08 Apr 2024 Quarterly Report – Period To 31 March 2024 Orthocell has today published its Quarterly Report for the period ended 31 March 2024. Orthocell
